DMK Pharmaceuticals Corporation
DMKPQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 83.81% | 4.12% | -168.76% | 24.36% | 47.61% |
| Total Depreciation and Amortization | -23.02% | -20.27% | -70.56% | -6.77% | 8.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -125.92% | 82.03% | 289.11% | 921.64% | 106.22% |
| Change in Net Operating Assets | -178.73% | -66.27% | 474.52% | 124.23% | -285.49% |
| Cash from Operations | -45.50% | -65.98% | -3.59% | 80.08% | 24.22% |
| Capital Expenditure | -- | -- | -- | 55.97% | 41.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 80,236.36% | -99.74% | 121.90% | -489.47% | -28.00% |
| Cash from Investing | 1,177.95% | -83.57% | 442.05% | -80.07% | -23.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,109,325.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -94.74% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -100.00% | 18,262.00% | -- | -- |
| Cash from Financing | 995,325.00% | -99.97% | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 100.00% | -- | -- | -- | -60.14% |
| Net Change in Cash | 343.68% | -221.85% | 250.79% | 79.27% | 27.39% |